September 14, 2017

Milbank Advises on $960M Debt Financing for Acquisition of Albany Molecular Research by Carlyle and GTCR

Share

Milbank, Tweed, Hadley & McCloy LLP advised Barclays, as administrative agent of the senior secured first-lien credit facilities, Morgan Stanley as administrative agent of the senior secured second-lien term loan facility, and Barclays, Morgan Stanley, RBC Capital Markets, Goldman Sachs, Jefferies and Mizuho as joint lead arrangers of the debt financing for the acquisition of Albany Molecular Research, Inc. by affiliates of The Carlyle Group and GTCR LLC. The debt financing consisted of a $655 million senior secured first-lien term loan facility, a $100 million multi-currency senior secured revolving credit facility, and a $205 million senior secured second-lien term loan facility. The transaction closed on August 31, 2017.

Albany Molecular Research, Inc. is a multinational contract research and manufacturing company focusing on the biotechnical and pharmaceutical industries.

The Carlyle Group is a global alternative asset manager and one of the world’s largest global private equity firms with approximately $170 billion of assets under management across 299 investment vehicles as of June 30, 2017.

GTCR LLC is private equity firm focused on investing in growth companies in Financial Services & Technology, Healthcare, Technology, Media & Telecommunications and Growth Business Services industries. Since its inception, it has invested over $12 billion in over 200 companies.

The Milbank Leveraged Finance team was led by partner Marcus Dougherty and included associates Charles Stern, Emily Rutcofsky and Yoon Hyun (Allison) Cho.

About Milbank

Milbank, Tweed, Hadley & McCloy LLP is a leading international law firm that provides innovative legal services to clients around the world. Founded in New York 150 years ago, Milbank has offices in Beijing, Frankfurt, Hong Kong, London, Los Angeles, Munich, São Paulo, Seoul, Singapore, Tokyo and Washington, DC. Milbank’s lawyers collaborate across practices and offices to help the world’s leading commercial, financial and industrial enterprises, as well as institutions, individuals and governments, achieve their strategic objectives.